OBI Pharma (4174) — Working Capital to Net Assets Ratio
OBI Pharma (4174) has a Working Capital to Net Assets ratio of 28.0% as of June 2026. Working capital of NT$614.28 Million (current assets of NT$841.46 Million minus current liabilities of NT$227.18 Million) is measured against net assets of NT$2.19 Billion. A higher ratio indicates strong short-term liquidity financed by the equity base. See OBI Pharma liquidity coverage in days to measure how many days the company can operate on defensive assets alone.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
OBI Pharma Working Capital to Net Assets (2011–2025)
This chart shows how OBI Pharma's Working Capital to Net Assets ratio has evolved across 15 annual periods from 2011 to 2025. As of June 2026, the ratio stands at 28.0%, reflecting working capital of NT$614.28 Million against net assets of NT$2.19 Billion TWD. For the complete balance sheet picture, see OBI Pharma asset portfolio.
Annual Working Capital to Net Assets for OBI Pharma (2011–2025)
The table below presents the year-by-year Working Capital to Net Assets ratio for OBI Pharma from 2011 to 2025, covering 15 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. Check 4174 cash and liquid asset ratio to evaluate the company's liquid asset resilience ratio.
| Year | WC/NA Ratio | Working Capital (TWD) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | 45.1% | NT$1.23 Billion | NT$2.73 Billion | NT$1.58 Billion | NT$350.56 Million | ▼ -17.7 pp |
| 2024 | 62.8% | NT$3.03 Billion | NT$4.82 Billion | NT$3.44 Billion | NT$412.37 Million | ▲ +2.2 pp |
| 2023 | 60.6% | NT$3.00 Billion | NT$4.95 Billion | NT$3.16 Billion | NT$158.62 Million | ▼ -17.8 pp |
| 2022 | 78.4% | NT$4.81 Billion | NT$6.14 Billion | NT$5.03 Billion | NT$221.14 Million | ▲ +13.2 pp |
| 2021 | 65.3% | NT$2.53 Billion | NT$3.87 Billion | NT$2.85 Billion | NT$327.22 Million | ▼ -10.1 pp |
| 2020 | 75.4% | NT$3.65 Billion | NT$4.84 Billion | NT$3.89 Billion | NT$248.49 Million | ▼ -11.2 pp |
| 2019 | 86.6% | NT$4.51 Billion | NT$5.20 Billion | NT$4.71 Billion | NT$200.00 Million | ▲ +4.1 pp |
| 2018 | 82.5% | NT$3.69 Billion | NT$4.47 Billion | NT$3.79 Billion | NT$103.82 Million | ▼ -9.3 pp |
| 2017 | 91.8% | NT$4.64 Billion | NT$5.06 Billion | NT$4.71 Billion | NT$68.65 Million | ▲ +30.4 pp |
| 2016 | 61.4% | NT$3.78 Billion | NT$6.16 Billion | NT$3.88 Billion | NT$97.46 Million | ▲ +30.3 pp |
| 2015 | 31.1% | NT$2.23 Billion | NT$7.18 Billion | NT$2.36 Billion | NT$127.00 Million | ▼ -30.8 pp |
| 2014 | 61.9% | NT$893.11 Million | NT$1.44 Billion | NT$937.35 Million | NT$44.24 Million | ▼ -3.6 pp |
| 2013 | 65.4% | NT$1.26 Billion | NT$1.93 Billion | NT$1.30 Billion | NT$41.46 Million | ▼ -23.2 pp |
| 2012 | 88.6% | NT$735.41 Million | NT$829.77 Million | NT$779.82 Million | NT$44.40 Million | ▲ +0.4 pp |
| 2011 | 88.2% | NT$448.51 Million | NT$508.44 Million | NT$462.78 Million | NT$14.27 Million | — |